Medicine
Inderal La 160 mg extended-release capsule
Inderal La 160 mg extended-release capsule is a prescription medicine containing Propranolol for oral use, marketed by ANI Pharmaceuticals, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Protect from light, moisture, freezing, and excessive heat. Store at 20° to…
Key facts
- Active ingredient (INN)
- Propranolol
- Brand
- Inderal La
- Strength
- 160 mg
- Dosage form
- Extended-release capsule
- Route
- Oral
- Packs
- 100 capsules, 30 capsules
- Marketing authorisation holder
- ANI Pharmaceuticals
- Manufacturer
- ANI Pharmaceuticals
- Origin register
- US FDA, United States
- Storage
- Protect from light, moisture, freezing, and excessive heat. Store at 20° to 25°C (68° to 77°F), excursions permitted to 15° to 30°C (59° to 86°F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- C07AA05 Propranolol
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 April 2017
- Identifiers
- RxCUI 856460, 856462, 856481 +5DailyMed set ID 35d28979-36b1-4630-b85e-a44e0a443734NDC 62559-523Application NDA018553
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 100 capsule, extended release in 1 bottle | 62559-523-01 | ANI Pharmaceuticals | 28 April 2017 |
| 30 capsule, extended release in 1 bottle | 62559-523-30 | ANI Pharmaceuticals | 5 August 2024 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Propranolol 160 mg extended-release capsule.
Other strengths and forms of Propranolol
Clinical summary
Propranolol is a beta-adrenergic blocker indicated in the management of hypertension, among other approved uses. It is available as tablets, extended-release capsules and oral solution for intravenous use. MedsAcross supplies Propranolol for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about PropranololFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Propranolol Hydrochloride ER prescribing information (ANI Pharmaceuticals) · U.S. National Library of Medicine, DailyMed
- Hemangiol: European public assessment report (EPAR) · European Medicines Agency
Need Inderal La 160 mg extended-release capsule for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.